Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
71
EWTX Quote, Financials, Valuation and Earnings
Last price:
$26.36
Seasonality move
:
-4%
Day range:
$25.36 - $27.39
52-week range:
$10.60 - $30.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.99x
Volume:
2.4M
Avg. volume:
1.8M
1-year change:
-11.16%
Market cap:
$2.8B
Revenue:
--
EPS (TTM):
-$1.58
Earnings Data
Next earnings date for EWTX
Mar 02
2026
Most recent earnings per share
-$0.39
Beat by $0.02
(Nov 6/2025)
Consensus Estimate
-$0.40
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EWTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/02/2026 | Q4 | -- | -- | -- | -$0.44 | -- |
| 11/06/2025 | Q3 | -- | -- | -$0.39 | -$0.40 | $0.02 |
| 08/08/2025 | Q2 | -- | -- | -$0.34 | -$0.42 | $0.07 |
| 05/08/2025 | Q1 | -- | -- | -$0.43 | -$0.42 | -$0.01 |
| 03/03/2025 | Q4 | -- | -- | -$0.42 | -$0.42 | $0.00 |
| 11/07/2024 | Q3 | -- | -- | -$0.36 | -$0.37 | $0.01 |
| 08/08/2024 | Q2 | -- | -- | -$0.34 | -$0.34 | $0.01 |
| 05/10/2024 | Q1 | -- | -- | -$0.33 | -$0.41 | $0.08 |
| 02/22/2024 | Q4 | -- | -- | -$0.47 | -$0.43 | -$0.03 |
| 11/09/2023 | Q3 | -- | -- | -$0.41 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.34 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.36 | -- | -- |
| 02/23/2023 | Q4 | -- | -- | -$0.31 | -- | -- |
| 11/03/2022 | Q3 | -- | -- | -$0.34 | -- | -- |
| 08/04/2022 | Q2 | -- | -- | -$0.32 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.30 | -- | -- |
| 02/24/2022 | Q4 | -- | -- | -$0.26 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.26 | -- | -- |
| 08/09/2021 | Q2 | -- | -- | -$0.21 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$0.14 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.14 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.08 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.06 | -- | -- |
Edgewise Therapeutics, Inc. Earnings Questions
-
How Much did Edgewise Therapeutics, Inc. Generate in Revenue Last Quarter?
Edgewise Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Edgewise Therapeutics, Inc. Beat Earnings Last Quarter?
Edgewise Therapeutics, Inc. announced earnings per share of -$0.39 which represents a beat of analyst forecast a -$0.40 per share.
-
Is Edgewise Therapeutics, Inc. Profitable?
Edgewise Therapeutics, Inc. reported -$570K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Edgewise Therapeutics, Inc. EPS Next Year?
Edgewise Therapeutics, Inc.'s earnings are forecast to decrease from -$1.45 per share to -$1.60 per share next year representing a decrease of -10.71%.
-
When is Edgewise Therapeutics, Inc.'s Earnings Date?
Edgewise Therapeutics, Inc.'s next earnings date is March 2, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
